During the past decade, Tianjin Huanhu Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 1 clinical trials were completed, i.e. on average, 5.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 1 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tianjin Huanhu Hospital" #1 sponsor was "Capital Medical University" with 3 trials, followed by "Beijing Tiantan Hospital" with 2 trials sponsored, "Jiangsu Simcere Pharmaceutical Co., Ltd." with 2 trials sponsored, "Bayer" with 1 trials sponsored and "Biohaven Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tianjin Huanhu Hospital" #1 collaborator was "Tianjin Huanhu Hospital" with 2 trials as a collaborator, "Affiliated Hospital of Nantong University" with 1 trials as a collaborator, "Baotou Central Hospital" with 1 trials as a collaborator, "Beijing Luhe Hospital" with 1 trials as a collaborator and "Beijing Municipal Science & Technology Commission" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Tianjin Huanhu Hospital" are "Acute Ischemic Stroke" (3 trials), "Alzheimer Disease" (2 trials), "Dementia" (2 trials), "Ischemic Stroke" (2 trials) and "Acute Ischaemic Stroke" (1 trials). Many other conditions were trialed in "Tianjin Huanhu Hospital" in a lesser frequency.

Most popular intervention types in "Tianjin Huanhu Hospital" are "Drug" (14 trials), "Procedure" (4 trials), "Device" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Compound Edaravone Injection" (2 trials), "Edaravone Injection" (2 trials), "11C-PiB" (1 trials) and "Alteplase" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tianjin Huanhu Hospital" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Tianjin Huanhu Hospital". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Tianjin Huanhu Hospital, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tianjin Huanhu Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".